These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design. Saravanamuthu A, Vickers TJ, Bond CS, Peterson MR, Hunter WN, Fairlamb AH. J Biol Chem; 2004 Jul 09; 279(28):29493-500. PubMed ID: 15102853 [Abstract] [Full Text] [Related]
26. Synthesis, inhibition potency, binding mode, and antiprotozoal activities of fluorescent inhibitors of trypanothione reductase based on mepacrine-conjugated diaryl sulfide scaffolds. Eberle C, Burkhard JA, Stump B, Kaiser M, Brun R, Krauth-Siegel RL, Diederich F. ChemMedChem; 2009 Dec 09; 4(12):2034-44. PubMed ID: 19847846 [Abstract] [Full Text] [Related]
27. Biological Evaluation and X-ray Co-crystal Structures of Cyclohexylpyrrolidine Ligands for Trypanothione Reductase, an Enzyme from the Redox Metabolism of Trypanosoma. De Gasparo R, Brodbeck-Persch E, Bryson S, Hentzen NB, Kaiser M, Pai EF, Krauth-Siegel RL, Diederich F. ChemMedChem; 2018 May 08; 13(9):957-967. PubMed ID: 29624890 [Abstract] [Full Text] [Related]